Welcome to BioReagent Hub Hotline:19920083827
本站自营/精选产品 www.yeasen.com  |  价格与库存以本站实时信息为准
本站精选 · 品质自营查看原始页面 ›
Vendor Tel:400-6111-883
Product data sheet PD-40184ES
Ceturegel® Matrix Phenol Red-Free,LDEV-Free基质胶 Ceturegel® Matrix Phenol Red-Free,LDEV-Free基质胶
Enquiry

Tell us your volume and application; we reply with a quote.

Start enquiry

Ceturegel® Matrix Phenol Red-Free,LDEV-Free基质胶

Scan for product
细胞培养类器官培养肿瘤研究
Product no.40184ES Sizes2 options SourceYeasen · Official
Cat. No. 40184ES08
现货 $1,368.00 促$1,865.00
Qty 1
Enquire now
Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status
40184ES08 5 mL $1,368.00促$1,865.00 现货 Enquire
40184ES10 10 mL $2,678.00促$3,655.00 现货 Enquire
Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen
Cat.No40184ES
Specification1、无污染:通过严格透析除菌,保证无细菌和真菌生长2、蛋白浓度:浓度8~20 mg/ml3、内毒素残留:含量<8EU/ml4、安全性高:不含LDEV残留5、产量高:单月批产量在50L级别以上6、支原体残留:检测验证无支原体污染
Origin翌圣生物科技(上海)股份有限公司
应用方法 细胞培养基础应用 类器官培养下游应用 肿瘤研究用于肿瘤细胞侵袭、迁移等研究
适用物种种属 小鼠
生物特性参数 细胞产品子类基质胶 来源EHS小鼠肿瘤 主要成分层粘连蛋白、IV型胶原、硫酸乙酰肝素蛋白聚糖、巢蛋白等 生长因子TGF-beta、EGF、IGF、FGF、组织纤溶酶原激活物等
样本类型 细胞
技术参数 浓度8-20 mg/mL 无菌性无菌 支原体检测无支原体污染 储存条件-20℃ 运输条件干冰运输 内毒素残留<8 EU/ml LDEV检测不含LDEV 不含酚红不含酚红
实验类型 3D细胞培养提供三维基质支撑 细胞侵袭实验作为侵袭研究基质支架 血管新生实验体内外血管新生研究的基质 皮下成瘤实验作为移植瘤细胞生长的三维支架 荧光检测实验无酚红干扰,适用于荧光检测

FAQ

Q:应用方向?

A:适应于2D和3D培养、侵袭和迁移实验,也可以用于体内成瘤实验

Q:40183与40184的区别?

A:40184是无酚红的,40183是含酚红的

Q:基质胶的保存温度,可以放-80保存吗?

A:可以的,-20和-80均是可以的

Q:基质胶中LDEV是什么?

A:乳酸脱氢酶增高病毒(LDEV)会感染小鼠巨噬细胞,并导致实验室小鼠群体的持续性感染。LDEV是一类RNA病毒,会改变小鼠的体内生理活动,是源自可移植肿瘤细胞系的生物试材的常见污染物。


Documents & Citations

Published citations

[1] Ren, W., Zheng, P., Zhou, Z., et al. (2025). Immunoglobulin-directed phase separation for cell-specific modulation of receptor signaling. Journal of the American Chemical Society, *147*(38), 34620-34631. doi: 10.1021/jacs.5c09699 (IF:15.7)

[2] Zhao, S., Liu, X., Luo, R., et al. (2025). USP38 functions as an oncoprotein by downregulating the p53 pathway through deubiquitination and stabilization of MDM2. Cell Death & Differentiation, *32*, 1128-1141. doi: 10.1038/s41418-025-01462-2 (IF:15.4)

[3] Hu, L., Ma, X., Cai, X., et al. (2026). The mitochondrial translocation of phosphorylated EZH2 promotes PARP inhibitor resistance in BRCA1-deficient epithelial ovarian cancer. Cell Discovery, *12*, 17. doi: 10.1038/s41421-026-00880-x (IF:13)

[4] Xiao, F., Zhu, H., Xiong, Y., Guo, Y., Zhang, Z., Zeng, J., Xiao, Y., Liao, B., Shang, X., Zhao, S., Hu, G., Huang, K., & Guo, H. (2024). Positive feedback loop of c-myc/XTP6/NDH2/NF-κB to promote malignant progression in glioblastoma. Journal of Experimental & Clinical Cancer Research, *43*(1), 187.  doi: 10.1186/s13046-024-03109-5 (IF:11.4)

[5] Zhou, X., Wang, J., Lu, M., Fang, L., Zhao, J., & Li, D. (2025). Leucine-rich repeat-containing 56 promotes breast cancer progression via modulation of the RhoA/ROCKs signaling axis. Molecular Biomedicine, *6*(1), 31. doi: 10.1186/s43556-025-00271-w (IF:10.1)


Recommended reading

Related products

✉Email 💬Message 👤Member
↑Top